C$27.5 Millon of Debt Extended from 2025 to 2029 Providing Additional Balance Sheet Flexibility SMITHS FALLS, ON, May 3, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), today announced that on May 2, 2024, it entered into an exchange and subscription agreement (the "Agreement") with a single institutional investor (the "Investor") pursuant to which Canopy Growth is expected to receive gross proceeds of approximately US$50 million and exchange appro ...

Investors are taking profits on marijuana stocks today, but the long-term trend still looks up.Easy come, easy go. Yesterday, shares of cannabis companies like Canopy Growth (CGC -25.96%), Tilray Brands (TLRY -17.01%), and Cronos Group (CRON -7.14%) all soared on news that the U.S. Drug Enforcement Administration (DEA) has agreed to recommend downgrading marijuana from a Schedule I drug to a Schedule III drug. Already today, the high is starting to wear off.As of 11:15 a.m. ET Wednesday, Canopy Growth stock ...

Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday.That rally came about after reports claimed the Biden Administration is moving forward with plans to reschedule cannabis from a Schedule I drug to a Schedule III drug. This would see it face fewer restrictions on research and open up tax breaks for companies in the field.This decision is a major win for cannabis stocks and it resulted in many shares climbing higher during norm ...

Following a major breakthrough, cannabis operators such as Canopy Growth (NASDAQ:CGC) saw their shares rise dramatically yesterday. As InvestorPlace’s Shrey Dua reported, President Joe Biden’s administration is moving to reschedule marijuana as a Schedule III substance. At the moment, cannabis carries the tougher Schedule I classification. With the decision potentially opening doors, CGC stock call options look mighty tempting.Fundamentally, the Schedule III downgrade would put marijuana on the same legal l ...

OlegMalyshev Listen here or on the go via Apple Podcasts and Spotify. Mario Naric, CEO and Founder of Motif Labs, discusses being in the shakeout phase of cannabis in Canada (1:00). Staying private while public companies suffer (5:25). How to grow market share in Canada (12:53). Near-term reality for big Canadian LPs like Tilray and Canopy Growth (18:00). Different products for different markets within US and Canada (23:20). Where should investors allocate their capital in this space? (40:40) Transcr ...

A January Pew Research survey indicates that 88% of U.S. adults support the legalization of cannabis for medicinal use. Further, 57% adults opine that the legalization should be for recreational use as well. The continued change in public opinion in favor of legalization might imply that it could have a chance of happening relatively soon at the federal level. With the presidential election due later this year, it’s a good time to look at cannabis stocks to buy for multibagger returns.While there are growin ...

Is Canopy Growth closer to entering the U.S. cannabis market?Canopy Growth (CGC 2.41%) is moving ahead with its plans for Canopy USA. After shareholders voted overwhelmingly in favor of its latest growth strategy for the U.S. pot market, the company is ready to take the next steps. Here's a look at what will those steps be, what they mean for investors, and whether these developments make Canopy Growth a better buy moving forward.What's next for Canopy Growth?Now that it has obtained shareholder approval, C ...

If you’re wondering what stocks to sell this quarter, you’re in the right place. Nothing lasts forever, not even stocks. During a 2018 all-hands meeting, Amazon (NASDAQ:AMZN) founder and then CEO Jeff Bezos famously said: “I predict one day Amazon will fail. Amazon will go bankrupt.” Apple (NASDAQ:AAPL) was on the verge of going bankrupt in 1997 before rival Microsoft (NASDAQ:MSFT) saved the then struggling company with a $150 million investment. History is littered with once famous companies and stocks tha ...

Is Another Green Rush On The Way For Marijuana StocksThe cannabis industry has rapidly become a significant sector within the stock market, attracting a diverse array of investors. Yet marijuana stocks are notorious for their volatility, influenced heavily by regulatory changes and political dynamics. This article explores essential strategies for investing in cannabis stocks during these fluctuating conditions. Plus highlights how political developments can impact the way most marijuana stocks trade. Navig ...

The progress toward legalization of cannabis in the United States continues at a slow pace, but medical marijuana is now permitted in approximately 37 states. Germany recently became the latest country to legalize cannabis for personal use beginning in April, coinciding with the informal holiday of 4/20. It’s the decriminalizing of cannabis at the federal level in the U.S. that would significantly advance the industry.It has been several months since the U.S. Department of Health and Human Services recommen ...